Dare Bioscience
DARE
23 hedge funds and large institutions have $84.5M invested in Dare Bioscience in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
47% more capital invested
Capital invested by funds: $57.3M → $84.5M (+$27.2M)
44% more funds holding
Funds holding: 16 → 23 (+7)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.55M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$257K |
| 3 |
SIM
Spark Investment Management
New York
|
+$183K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$114K |
| 5 |
Goldman Sachs
New York
|
+$63.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$565K |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$392K |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$80.3K |
DARE Hedge Fund Activity: Q1 2015 in Review
23 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2015, worth a combined $84.5M — up 47% from $57.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DARE positions and 0 closed out — a net gain of 7 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Granahan Investment Management, opening a new position worth an estimated $1.55M. The largest seller was Fidelity Investments, cutting an estimated $565K.
- 23 institutional investors held Dare Bioscience (DARE) as of Q1 2015, up from 16 in Q4 2014.
- Funds reported $84.5M of Dare Bioscience stock for Q1 2015, up 47% quarter-over-quarter.
- 7 funds opened new Dare Bioscience positions in Q1 2015 and 0 closed out, a net change of +7 holders.
- The largest Dare Bioscience buyer in Q1 2015 was Granahan Investment Management, an estimated $1.55M added.
- The largest Dare Bioscience seller in Q1 2015 was Fidelity Investments, an estimated $565K sold.
Based on aggregated 13F filings for Q1 2015.